These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35309123)

  • 21. XAF1 is frequently methylated in human esophageal cancer.
    Chen XY; He QY; Guo MZ
    World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of STAT3 and FOXO1 in the Divergent Therapeutic Responses of Non-metastatic and Metastatic Bladder Cancer Cells to miR-145.
    Jiang G; Huang C; Li J; Huang H; Jin H; Zhu J; Wu XR; Huang C
    Mol Cancer Ther; 2017 May; 16(5):924-935. PubMed ID: 28223425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma.
    Ward EC; Hoekstra AV; Blok LJ; Hanifi-Moghaddam P; Lurain JR; Singh DK; Buttin BM; Schink JC; Kim JJ
    Endocrinology; 2008 Apr; 149(4):1942-50. PubMed ID: 18096667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological significance of PTPN12 expression in human breast cancer.
    Xunyi Y; Zhentao Y; Dandan J; Funian L
    Braz J Med Biol Res; 2012 Dec; 45(12):1334-40. PubMed ID: 23044628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells.
    Diep CH; Charles NJ; Gilks CB; Kalloger SE; Argenta PA; Lange CA
    Cell Cycle; 2013 May; 12(9):1433-49. PubMed ID: 23574718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-96 regulates FOXO1-mediated cell apoptosis in bladder cancer.
    Guo Y; Liu H; Zhang H; Shang C; Song Y
    Oncol Lett; 2012 Sep; 4(3):561-565. PubMed ID: 23741253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Protein Expression and Methylation of DAPK1 with Clinicopathological Features in Invasive Ductal Carcinoma Patients from Kashmir.
    Asiaf A; Ahmad ST; Malik AA; Aziz SA; Zargar MA
    Asian Pac J Cancer Prev; 2019 Mar; 20(3):839-848. PubMed ID: 30912402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JNK-dependent downregulation of FoxO1 is required to promote the survival of fibroblast-like synoviocytes in rheumatoid arthritis.
    Grabiec AM; Angiolilli C; Hartkamp LM; van Baarsen LG; Tak PP; Reedquist KA
    Ann Rheum Dis; 2015 Sep; 74(9):1763-71. PubMed ID: 24812285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells.
    Guttilla IK; White BA
    J Biol Chem; 2009 Aug; 284(35):23204-16. PubMed ID: 19574223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant promoter methylation of PCDH10 as a potential diagnostic and prognostic biomarker for patients with breast cancer.
    Liu W; Wu J; Shi G; Yue X; Liu D; Zhang Q
    Oncol Lett; 2018 Oct; 16(4):4462-4470. PubMed ID: 30214581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between promoter methylation of the LDH-C4 gene and DNMT expression in breast cancer and their prognostic significance.
    Zhang J; Zhang F; Zhang F; Wu H; Zhang B; Wu X
    Oncol Lett; 2022 Jan; 23(1):35. PubMed ID: 34966451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Forkhead box O1 as an indicator of prognosis is inactivated in urothelial carcinoma of the upper urinary tract.
    Ide H; Jiang G; Mizushima T; Fujita K; Inoue S; Yamaguchi S; Fushimi H; Nonomura N; Miyamoto H
    Oncol Lett; 2019 Jan; 17(1):482-487. PubMed ID: 30655790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
    Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic implications of forkhead box protein O1 (FOXO1) and paired box 3 (PAX3) in epithelial ovarian cancer.
    Han GH; Chay DB; Nam S; Cho H; Chung JY; Kim JH
    BMC Cancer; 2019 Dec; 19(1):1202. PubMed ID: 31823759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermediate filament dynamics and breast cancer: aberrant promoter methylation of the Synemin gene is associated with early tumor relapse.
    Noetzel E; Rose M; Sevinc E; Hilgers RD; Hartmann A; Naami A; Knüchel R; Dahl E
    Oncogene; 2010 Aug; 29(34):4814-25. PubMed ID: 20543860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miRNA-223 suppresses FOXO1 and functions as a potential tumor marker in breast cancer.
    Wei YT; Guo DW; Hou XZ; Jiang DQ
    Cell Mol Biol (Noisy-le-grand); 2017 May; 63(5):113-118. PubMed ID: 28719355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SIRT1-mediated FoxO1 deacetylation is essential for multidrug resistance-associated protein 2 expression in tamoxifen-resistant breast cancer cells.
    Choi HK; Cho KB; Phuong NT; Han CY; Han HK; Hien TT; Choi HS; Kang KW
    Mol Pharm; 2013 Jul; 10(7):2517-27. PubMed ID: 23763570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The high protein expression of FOXO3, but not that of FOXO1, is associated with markers of good prognosis.
    Lallemand F; Vacher S; de Koning L; Petitalot A; Briaux A; Driouch K; Callens C; Schnitzler A; Lecerf C; Oulie-Bard F; Barbet A; Vincent A; Zinn-Justin S; Lopez BS; Lidereau R; Bieche I; Caputo SM
    Sci Rep; 2020 Apr; 10(1):6920. PubMed ID: 32332845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of phosphorylated FOXO1 expression in soft tissue sarcoma.
    Zhang B; Tomita Y; Ch'ng E; Qiu Y; He J; Jin YF; Tomoeda M; Hamada K; Ueda T; Aozasa K
    Ann Surg Oncol; 2009 Jul; 16(7):1925-37. PubMed ID: 19408047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ADAM33 gene silencing by promoter hypermethylation as a molecular marker in breast invasive lobular carcinoma.
    Seniski GG; Camargo AA; Ierardi DF; Ramos EA; Grochoski M; Ribeiro ES; Cavalli IJ; Pedrosa FO; de Souza EM; Zanata SM; Costa FF; Klassen G
    BMC Cancer; 2009 Mar; 9():80. PubMed ID: 19267929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.